Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial

BACKGROUND: WHO 2013 guidelines recommend universal treatment for HIV-infected children younger than 5 years. No paediatric trials have compared nucleoside reverse-transcriptase inhibitors (NRTIs) in first-line antiretroviral therapy (ART) in Africa, where most HIV-infected children live. We aimed t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet Infect Dis
Hlavní autoři: Mulenga, Veronica, Musiime, Victor, Kekitiinwa, Adeodata, Cook, Adrian D, Abongomera, George, Kenny, Julia, Chabala, Chisala, Mirembe, Grace, Asiimwe, Alice, Owen-Powell, Ellen, Burger, David, McIlleron, Helen, Klein, Nigel, Chintu, Chifumbe, Thomason, Margaret J, Kityo, Cissy, Walker, A Sarah, Gibb, Diana M
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier Science ;, The Lancet Pub. Group 2016
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4726762/
https://ncbi.nlm.nih.gov/pubmed/26481928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00319-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky